carbapenems has been researched along with zithromax in 8 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (zithromax) | Trials (zithromax) | Recent Studies (post-2010) (zithromax) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 6,964 | 1,263 | 3,790 |
Protein | Taxonomy | carbapenems (IC50) | zithromax (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.3 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.3 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 6 (75.00) | 2.80 |
Authors | Studies |
---|---|
Duff, P | 1 |
Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
Allen, VG; Bharat, A; Eshaghi, A; Mulvey, MR; Patel, SN; Zittermann, S | 1 |
Aydoğan, CN; Bozdoğan, B; Gümral, R; Hoşbul, T; Kaya, S; Levent, B; Şahiner, F; Türkmen Albayrak, H | 1 |
Camacho-Ortiz, A; Flores-Treviño, S; Garza-González, E; Lara-Medrano, R; Martínez-Reséndez, MF; Mendoza-Olazarán, S | 1 |
Barker, KR; Britton, PN; Campigotto, A; Castelli, F; Chan, T; Earl, AM; Farrar, DS; Fumadó, VP; Hagmann, SHF; Hamer, DH; LaRocque, RC; Libman, M; Morris, SK; Posen, HJ; Ryan, ET; Wong, W; Worby, CJ | 1 |
Goy, K; Luna, B; Miller, S; She, R; Spellberg, B | 1 |
Bissong, MEA; Mkong, PB; Mobey, KN; Muma, V | 1 |
1 review(s) available for carbapenems and zithromax
Article | Year |
---|---|
Antibiotic selection in obstetrics: making cost-effective choices.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbapenems; Cephalosporins; Clindamycin; Cost-Benefit Analysis; Female; Fluoroquinolones; Humans; Linezolid; Metronidazole; Nitrofurantoin; Oxazolidinones; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
7 other study(ies) available for carbapenems and zithromax
Article | Year |
---|---|
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
Topics: Anti-Bacterial Agents; Azithromycin; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Ontario; Pakistan; Salmonella enterica; Travel; Typhoid Fever; Whole Genome Sequencing | 2020 |
[Investigation of Azithromycin Minimum Inhibitory Concentration Values and Carbapenem Resistance in Salmonella and Shigella Clinical Isolates].
Topics: Anti-Bacterial Agents; Azithromycin; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Salmonella; Shigella | 2021 |
Azithromycin effect on multidrug resistant Acinetobacter baumannii biofilm production and composition.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Azithromycin; Biofilms; Carbapenems; Humans | 2021 |
Travel-associated extensively drug-resistant typhoid fever: a case series to inform management in non-endemic regions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Carbapenems; Humans; Pakistan; Salmonella typhi; Travel; Typhoid Fever | 2023 |
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Azithromycin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moths | 2023 |
Reduced susceptibility to carbapenems in
Topics: Animals; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Cameroon; Carbapenems; Cattle; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Microbial Sensitivity Tests | 2023 |